This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Prognosis

Authoring team

  • Poor median survival rates in untreated patients - 2.8 years from diagnosis (1):
    • previous 5 year survival was 40% but this has been improved with advances in medical therapy
  • Chronic thromboembolic pulmonary hypertension (CTEPH):
    • majority of patients can be cured with normalisation of pulmonary pressure following pulmonary endarterectomy surgery with improvement in symptoms and prognosis, with a > 90% 5 year survival
  • In some patients with pulmonary hypertension, bilateral lung or heart lung transplantation may be considered. The 5 year survival following transplantation is approximately 50-60%.
  • Development of cor pulmonale as a result of a primary pulmonary disease usually heralds a poorer prognosis (2).

References:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.